Developing new products for HIV prevention in children
Official title: Resources to Advance Pediatrics and HIV Prevention Science (RAPPS): Preclinical Gap- Filling Services
Funded at Sri International · NIH-10850753 · Data updated 2026-11-12
This study is working to create and test new treatments and prevention methods for HIV, especially for children, by bringing together ideas from schools and companies to help make these products available and effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | April 15, 2023 |
| Project end | April 14, 2028 |
| Funding year | 2023 |
| Award (this year) | $45,041 |
| NIH project number | 75N93023D00002-0-759302300001-1 |
| Project ID | NIH-10850753 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and adolescents at risk for HIV or those living with HIV, particularly in communities with high prevalence rates.
✕Less likely to help
Patients who are not at risk for HIV or who are not within the pediatric age group may not receive benefits from this research.
What this research studies
This research aims to provide essential resources and support for the development of new therapeutic and preventive products targeting HIV, particularly for pediatric populations. It focuses on filling gaps in preclinical product development, which includes creating and testing candidate products that arise from academic and private sector collaborations. By advancing promising products into clinical testing, this initiative seeks to enhance the effectiveness of HIV prevention strategies, including those that may also address co-infections and incorporate contraceptive methods.
Why it matters
Potential benefit: If successful, this research could lead to innovative HIV prevention products specifically designed for children, improving their health outcomes.
How similar studies have gone: Previous research has shown success in developing HIV prevention strategies, but this approach focuses specifically on pediatric needs, making it a novel initiative.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Evans, Laura — Sri International
- Study coordinator: Evans, Laura
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.